Advertisement

Pediatric Invasive Fungal Infections

  • Andreas GrollEmail author
  • Romana Klasinc
  • Luigi Segagni-Lusignani
Chapter

Abstract

Invasive fungal infections are increasing in incidence and constitute an important cause for morbidity and mortality in immunocompromised pediatric patient populations, including but not limited to preterm neonates, critically ill children and adolescents in the intensive care unit and those with hematological malignancies or undergoing hematopoietic stem cell transplantation. Infections in these patients are due to Candida, Aspergillus, and other less common opportunistic fungi. While children and adolescents are similarly vulnerable to invasive fungal infections, important differences exist relative to adults. This chapter reviews current epidemiology of invasive fungal infections in pediatric patients, new emerging diagnostic modalities and current concepts for treatment and prevention.

References

  1. 1.
    Zingg W, Hopkins S, Gayet-Ageron A, Holmes A, Sharland M, Suetens C, Almeida M, Asembergiene J, Borg MA, Budimir A, Cairns S, Cunney R, Deptula A, Berciano PG, Gudlaugsson O, Hadjiloucas A, Hammami N, Harrison W, Heisbourg E, Kolman J, Kontopidou F, Kristensen B, Lyytikäinen O, Märtin P, McIlvenny G, Moro ML, Piening B, Presterl E, Serban R, Smid E, Sorknes NK, Stefkovicova M, Sviestina I, Szabo R, Tkadlecova H, Vatcheva-Dobrevska R, VerjatTrannoy D (2017) Health-care-associated infections in neonates, children, and adolescents: an analysis of paediatric data from the European Centre for Disease Prevention and Control point-prevalence survey. Lancet Infect Dis 17(4):381–389PubMedCrossRefGoogle Scholar
  2. 2.
    Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C (2005) The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 41(9):1232–1239PubMedCrossRefGoogle Scholar
  3. 3.
    Zaoutis TE, Coffin SE, Chu JH, Heydon K, Zhao H, Greves HM, Walsh TJ (2005) Risk factors for mortality in children with candidemia. Pediatr Infect Dis J 24(8):736–739PubMedCrossRefGoogle Scholar
  4. 4.
    Baptista MI, Nona J, Ferreira M, Sampaio I, Abrantes M, Tome MT, Neto MT, Barroso R, Serelha M, Virella D (2016) Invasive fungal infection in neonatal intensive care units: a multicenter survey. J Chemother 28(1):37–43PubMedCrossRefGoogle Scholar
  5. 5.
    Zaoutis TE, Prasad PA, Localio AR, Coffin SE, Bell LM, Walsh TJ, Gross R (2010) Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis 51(5):e38–e45PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Roilides E, Kadiltsoglou I, Zahides D, Bibashi E (1997) Invasive candidosis in pediatric patients. Clin Microbiol Infect 3(2):192–197PubMedCrossRefGoogle Scholar
  7. 7.
    Zaoutis T (2010) Candidemia in children. Curr Med Res Opin 26(7):1761–1768PubMedCrossRefGoogle Scholar
  8. 8.
    Tragiannidis A, Fegeler W, Rellensmann G, Debus V, Müller V, Hörnig-Franz I, Siam K, Pama ZD, Jürgens H, Groll AH (2012a) Candidaemia in a European Paediatric University Hospital: a 10-year observational study. Clin Microbiol Infect 18:E27–E30PubMedCrossRefGoogle Scholar
  9. 9.
    Tragiannidis A, Roilides E, Walsh T, Groll AH (2012) Invasive aspergillosis in children with acquired immunodeficiencies. Clin Infect Dis 54(2):258–267PubMedCrossRefGoogle Scholar
  10. 10.
    Pasqualotto AC, de Moraes AB, Zanini RR, Severo LC (2007) Analysis of independent risk factors for death among pediatric patients with candidemia and a central venous catheter in place. Infect Control Hosp Epidemiol 28(7):799–804PubMedCrossRefGoogle Scholar
  11. 11.
    Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, Laptook AR, Sanchez PJ, Van Meurs KP, Wyckoff M, Das A, Hale EC, Ball MB, Newman NS, Schibler K, Poindexter BB, Kennedy KA, Cotten CM, Watterberg KL, D’Angio CT, DeMauro SB, Truog WE, Devaskar U, Higgins RD (2015) Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 314(10):1039–1051Google Scholar
  12. 12.
    Benjamin DK Jr, Ross K, McKinney RE Jr, Benjamin DK, Auten R, Fisher RG (2000) When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics 106(4):712–718PubMedCrossRefGoogle Scholar
  13. 13.
    Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin RT, Dawson J, Blumberg HM, Patterson JE, Rinaldi M, Edwards JE, Wenzel RP, Jarvis W (2000) Risk factors for candidemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey Study Group. Pediatr Infect Dis J 19(4):319–324PubMedCrossRefGoogle Scholar
  14. 14.
    Hammarskjold F, Mernelius S, Andersson RE, Berg S, Hanberger H, Lofgren S, Malmvall BE, Petzold M, Matussek A (2013) Possible transmission of Candida albicans on an intensive care unit: genotype and temporal cluster analyses. J Hosp Infect 85(1):60–65PubMedCrossRefGoogle Scholar
  15. 15.
    Pfaller MA (1996) Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect Dis 22(Suppl 2):S89–S94PubMedCrossRefGoogle Scholar
  16. 16.
    Schnell JD (1977) The epidemiology and prophylaxis of mycoses in perinatology. Contrib Microbiol Immunol 4:40–45PubMedGoogle Scholar
  17. 17.
    Kaufman DA (2010) Challenging issues in neonatal candidiasis. Curr Med Res Opin 26(7):1769–1778PubMedCrossRefGoogle Scholar
  18. 18.
    Mendling W, Friese K, Mylonas I, Weissenbacher ER, Brasch J, Schaller M, Mayser P, Effend I, Ginter-Hanselmayer G, Hof H, Cornely O, Ruhnke M (2015) Vulvovaginal candidosis. Guideline of the German Society of Gynecology and Obstretrics. Geburtshilfe Frauenheilkd. 75:342–354PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Leibovitz E (2012) Strategies for the prevention of neonatal candidiasis. Pediatr Neonatol 53(2):83–89PubMedCrossRefGoogle Scholar
  20. 20.
    Manzoni P, Farina D, Leonessa M, d’Oulx EA, Galletto P, Mostert M, Miniero R, Gomirato G (2006) Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics 118(6):2359–2364PubMedCrossRefGoogle Scholar
  21. 21.
    Manzoni P, Mostert M, Leonessa ML, Priolo C, Farina D, Monetti C, Latino MA, Gomirato G (2006) Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis 42(12):1735–1742PubMedCrossRefGoogle Scholar
  22. 22.
    Aliaga S, Clark RH, Laughon M, Walsh TJ, Hope WW, Benjamin DK, Kaufman D, Arrieta A, Benjamin DK Jr, Smith PB (2014) Changes in the incidence of candidiasis in neonatal intensive care units. Pediatrics 133(2):236–242PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Kelly MS, Benjamin DK Jr, Smith PB (2015) The epidemiology and diagnosis of invasive candidiasis among premature infants. Clin Perinatol 42(1):105–117 viii-ixPubMedCrossRefGoogle Scholar
  24. 24.
    Roilides E, Antachopoulos C, Groll AH, Walsh TJ (2017) Chapter 39: candidiasis. In: Succinct pediatrics: evaluation and management for infectious diseases and dermatologic disorders. American Academy of Pediatris, Elk Grove Village, pp 435–452Google Scholar
  25. 25.
    Hope WW, Castagnola E, Groll AH, Roilides E, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Cornely OA, Cuenca-Estrella M, Donnelly JP, Garbino J, Herbrecht R, Jensen HE, Kullberg BJ, Lass-Florl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Verweij PE, Viscoli C, Ullmann AJ, E. F. I. S. Group (2012) ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect 18(Suppl 7):38–52PubMedCrossRefGoogle Scholar
  26. 26.
    Blyth CC, Chen SC, Slavin MA, Serena C, Nguyen Q, Marriott D, Ellis D, Meyer W, Sorrell TC (2009) Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics. 123(5):1360–1368PubMedCrossRefGoogle Scholar
  27. 27.
    Noyola DE, Fernandez M, Moylett EH, Baker CJ (2001) Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia. Clin Infect Dis 32(7):1018–1023PubMedCrossRefGoogle Scholar
  28. 28.
    Tissieres P, Jaeggi ET, Beghetti M, Gervaix A (2005) Increase of fungal endocarditis in children. Infection 33(4):267–272PubMedCrossRefGoogle Scholar
  29. 29.
    Meersseman W, Lagrou K, Spriet I, Maertens J, Verbeken E, Peetermans WE, Van Wijngaerden E (2009) Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med 35(9):1526–1531CrossRefGoogle Scholar
  30. 30.
    Gamaletsou MN, Kontoyiannis DP, Sipsas NV, Moriyama B, Alexander E, Roilides E, Brause B, Walsh TJ (2012) Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970–2011). Clin Infect Dis. 55(10):1338–1351PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Kirkpatrick C (1993) Chronic mucocutaneous candidiasis. In: Bodey GP (ed) Candidiasis. Raven Press, New York, pp 167–184Google Scholar
  32. 32.
    Casanova JL (2015) Severe infectious diseases of childhood as monogenic inborn errors of immunity. Proc Natl Acad Sci U S A 112(51):E7128–E7137PubMedPubMedCentralGoogle Scholar
  33. 33.
    Pilmis B, Puel A, Lortholary O, Lanternier F (2016) New clinical phenotypes of fungal infections in special hosts. Clin Microbiol Infect 22(8):681–687PubMedCrossRefGoogle Scholar
  34. 34.
    Berenguer J, Buck M, Witebsky F, Stock F, Pizzo PA, Walsh TJ (1993) Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn Microbiol Infect Dis 17(2):103–109PubMedCrossRefGoogle Scholar
  35. 35.
    Cuenca-Estrella M, Verweij PE, Arendrup MC, Arikan-Akdagli S, Bille J, Donnelly JP, Jensen HE, Lass-Florl C, Richardson MD, Akova M, Bassetti M, Calandra T, Castagnola E, Cornely OA, Garbino J, Groll AH, Herbrecht R, Hope WW, Kullberg BJ, Lortholary O, Meersseman W, Petrikkos G, Roilides E, Viscoli C, Ullmann AJ, E. F. I. S. Group (2012) ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 18(Suppl 7):9–18CrossRefGoogle Scholar
  36. 36.
    Groll AH, Castagnola E, Cesaro S, Dalle JH, Engelhard D, Hope W, Roilides E, Styczynski J, Warris A, Lehrnbecher T, Fourth European Conference on Infections in Leukaemia; Infectious Diseases Working Party of the European Group for Blood Marrow Transplantation (EBMT-IDWP); Infectious Diseases Group of the European Organisation for Research and Treatment of Cancer (EORTC-IDG); International Immunocompromised Host Society (ICHS); European Leukaemia Net (ELN) (2014) Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncol 15(8):e327–e340PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Katragkou A, Roilides E (2011) Best practice in treating infants and children with proven, probable or suspected invasive fungal infections. Curr Opin Infect Dis. 24(3):225–229PubMedCrossRefGoogle Scholar
  38. 38.
    Queiroz-Telles F, Berezin E, Leverger G, Freire A, van der Vyver A, Chotpitayasunondh T, Konja J, Diekmann-Berndt H, Koblinger S, Groll AH, Arrieta A (2008) Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. Pediatr Infect Dis J 27(9):820–826PubMedCrossRefGoogle Scholar
  39. 39.
    Wiley JM, Seibel NL, Walsh TJ (2005) Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections. Pediatr Infect Dis J 24(2):167–174PubMedCrossRefGoogle Scholar
  40. 40.
    Walsh TJ, Lutsar I, Driscoll T, Dupont B, Roden M, Ghahramani P, Hodges M, Groll AH, Perfect JR (2002) Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 21(3):240–248PubMedCrossRefGoogle Scholar
  41. 41.
    Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG (2001) Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 345(23):1660–1666PubMedCrossRefGoogle Scholar
  42. 42.
    Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Grossman LB (2005) Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight. J Pediatr 147(2):172–179PubMedCrossRefGoogle Scholar
  43. 43.
    Kicklighter SD, Springer SC, Cox T, Hulsey TC, Turner RB (2001) Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics. 107(2):293–298PubMedCrossRefGoogle Scholar
  44. 44.
    Manzoni P, Stolfi I, Pugni L, Decembrino L, Magnani C, Vetrano G, Tridapalli E, Corona G, Giovannozzi C, Farina D, Arisio R, Merletti F, Maule M, Mosca F, Pedicino R, Stronati M, Mostert M, Gomirato G, Italian Task Force for the Study and Prevention of Neonatal Fungal Infections; Italian Society of Neonatology (2007) A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med. 356(24):2483–2495PubMedCrossRefGoogle Scholar
  45. 45.
    Manzoni P, Leonessa M, Galletto P, Latino MA, Arisio R, Maule M, Agriesti G, Gastaldo L, Gallo E, Mostert M, Farina D (2008) Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies. Pediatr Infect Dis J. 27(8):731–737PubMedCrossRefGoogle Scholar
  46. 46.
    Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR, Greinix H, Morais de Azevedo W, Reddy V, Boparai N, Pedicone L, Patino H, Durrant S (2007) Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356(4):335–347PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med. 356(4):348–359PubMedCrossRefGoogle Scholar
  48. 48.
    Maertens JA, Madero L, Reilly AF, Lehrnbecher T, Groll AH, Jafri HS, Green M, Nania JJ, Bourque MR, Wise BA, Strohmaier KM, Taylor AF, Kartsonis NA, Chow JW, Arndt CA, DePauw BE, Walsh TJ (2010) A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia. Pediatr Infect Dis J 29(5):415–420PubMedCrossRefGoogle Scholar
  49. 49.
    Groll AH, Antachopoulos C, Roilides E, Walsh TJ (2017) Chapter 38: aspergillosis. In: Succinct pediatrics: evaluation and management for infectious diseases and dermatologic disorders. American Academy of Pediatris, Elk Grove Village, pp 425–434Google Scholar
  50. 50.
    Lehrnbecher T, Robinson PD, Fisher BT, Castagnola E, Groll AH, Steinbach WJ, Zaoutis TE, Negeri ZF, Beyene J, Phillips B, Sung L (2016) Galactomannan, β-D-glucan, and polymerase chain reaction-based assays for the diagnosis of invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review and meta-analysis. Clin Infect Dis 63(10):1340–1348PubMedCrossRefGoogle Scholar
  51. 51.
    Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347(6):408–415PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Ullmann A, Aguado JM, Arikan S, Denning D, Groll A, Lagrou K, Lass-Florl C, Lewis R, Muñoz P, Verweij P, Warris A, Akova M, Arendrup MC, Barnes R, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, cadranel J, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Gangneux J-P, Garbino J, Heinz W, Herbrecht R, Kibbler C, Klimko N, Kullberg B-J, Lange C, Lehrnbecher T, Loeffler J, Lortholary O, Maertens J, Cornely O (2018) Diagnosis and management of aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect 24(Suppl. 1):e1–e38PubMedCrossRefGoogle Scholar
  53. 53.
    Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Ullmann AJ, Bouza E, Heussel CP, Lortholary O, Rieger C, Boehme A, Aoun M, Horst HA, Thiebaut A, Ruhnke M, Reichert D, Vianelli N, Krause SW, Olavarria E, Herbrecht R, AmBiLoad Trial Study Group (2007) Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis. 44(10):1289–1297PubMedCrossRefGoogle Scholar
  54. 54.
    Dornbusch HJ, Manzoni P, Roilides E, Walsh TJ, Groll AH (2009) Invasive fungal infections in children. Pediatr Infect Dis J 28(8):734–737PubMedCrossRefGoogle Scholar
  55. 55.
    Walsh TJ, Karlsson MO, Driscoll T, Arguedas AG, Adamson P, Saez-Llorens X, Vora AJ, Arrieta AC, Blumer J, Lutsar I, Milligan P, Wood N (2004) Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration. Antimicrob Agents Chemother 48(6):2166–2172PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE (2004) Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 351(14):1391–1402CrossRefGoogle Scholar
  57. 57.
    Zaoutis TE, Roilides E, Chiou CC, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Prasad PA, Chu JH, Walsh TJ (2007) Zygomycosis in children: a systematic review and analysis of reported cases. Pediatr Infect Dis J. 26(8):723–727PubMedCrossRefGoogle Scholar
  58. 58.
    Roilides E, Zaoutis TE, Walsh TJ (2009) Invasive zygomycosis in neonates and children. Clin Microbiol Infect. 15(Suppl 5):50–54PubMedCrossRefGoogle Scholar
  59. 59.
    Gonzalez CE, Shetty D, Lewis LL, Mueller BU, Pizzo PA, Walsh TJ (1996) Cryptococcosis in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 15(9):796–800PubMedCrossRefGoogle Scholar
  60. 60.
    Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella M, Freiberger T, Guinea J, Guarro J, de Hoog S, Hope W, Johnson E, Kathuria S, Lackner M, Lass-Flörl C, Lortholary O, Meis JF, Meletiadis J, Muñoz P, Richardson M, Roilides E, Tortorano AM, Ullmann AJ, van Diepeningen A, Verweij P, Petrikkos G, European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology (2014) ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect 20(Suppl 3):5–26PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Chowdhary A, Meis JF, Guarro J, de Hoog GS, Kathuria S, Arendrup MC, Arikan-Akdagli S, Akova M, Boekhout T, Caira M, Guinea J, Chakrabarti A, Dannaoui E, van Diepeningen A, Freiberger T, Groll AH, Hope WW, Johnson E, Lackner M, Lagrou K, Lanternier F, Lass-Flörl C, Lortholary O, Meletiadis J, Muñoz P, Pagano L, Petrikkos G, Richardson MD, Roilides E, Skiada A, Tortorano AM, Ullmann AJ, Verweij PE, Cornely OA, Cuenca-Estrella M, European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology (2014) ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect 20(Suppl 3):47–75PubMedCrossRefGoogle Scholar
  62. 62.
    Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, Munoz P, Johnson E, Meletiadis J, Pana ZD, Lackner M, Verweij P, Freiberger T, Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella M, Guinea J, Guarro J, de Hoog S, Hope W, Kathuria S, Lortholary O, Meis JF, Ullmann AJ, Petrikkos G, Lass-Flörl C, European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology (2014) ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect 20(Suppl 3):27–46CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Andreas Groll
    • 1
    Email author
  • Romana Klasinc
    • 2
  • Luigi Segagni-Lusignani
    • 2
  1. 1.Infectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology/OncologyUniversity Children’s Hospital MünsterMünsterGermany
  2. 2.Department of Infection Control and Hospital EpidemiologyMedical University of ViennaViennaAustria

Personalised recommendations